Vyaire Medical

What Vyaire Medical does

Vyaire Medical is a privately held US medical device company headquartered in Lake Forest, Illinois, specializing in respiratory care technology. Founded in 2016, the company historically operated two business units — Ventilators and Respiratory Diagnostics — serving acute care hospitals, intensive care units (ICUs), neonatal intensive care units (NICUs), and emergency medical services. Its product portfolio spanned the full patient continuum from neonatal to adult care, with both invasive and non-invasive ventilation modalities, and included proprietary technologies such as continuous cuff pressure monitoring, high-frequency oscillatory ventilation (HFOV, 3100 HFOV line), and the Bird MicroBlender precision FiO2 delivery device. Vyaire distributed products globally through direct sales to healthcare facilities and authorized distributor networks.

In 2024, Vyaire underwent a major strategic restructuring. ZOLL Medical acquired the company's Ventilation Business Unit — encompassing the bellavista, LTV, 3100 HFOV, and fabian ventilator product lines along with related consumables, service parts, and service programs — in a transaction announced August 2024 and completed October 11, 2024. Maxtec separately acquired the Bird MicroBlender product line on December 3, 2024. Following these divestitures, Vyaire retained its Respiratory Diagnostics business unit and continued to expand its neonatal respiratory portfolio, positioning itself as a focused player in cardiorespiratory diagnostics and NICU respiratory care.

The company built its early scale through acquisition, including Ciel Medical (2017), Revolutionary Medical Devices (2017), and Acutronic Medical Systems (2018). Leadership disclosed includes a CFO (Tracy C. Jokinen), Chief Supply Chain and Quality Officer, VP/Medical Director, Director of R&D, Senior Director of Global Supply Chain, and Principal Designer. Public financial details — revenue, pricing, certifications, and patents — are not disclosed in available sources.

Name

Vyaire Medical

Website

https://vyaire.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Vyaire Medical is a private US medical device company specializing in respiratory care, serving hospitals, ICUs, NICUs, and EMS providers. Following 2024 divestitures of its ventilator business to ZOLL Medical and Bird MicroBlender to Maxtec, the company retains its Respiratory Diagnostics unit and an expanded neonatal respiratory portfolio.

Ownership category

akta.pro rank

Product category

Respiratory Care Medical Devices

NAICS

Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413)

SIC

Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564)

akta.pro primary industry

Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

Keywords

• Respiratory care devices
• Medical ventilation equipment
• Cardiorespiratory diagnostics
• Neonatal ventilators
• Critical care medical devices

Headquarters

HQ city

Lake Forest

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels2 records

Marketing channels1 record

Core offering

Vyaire Medical is a global medical device company that develops, manufactures, and sells respiratory care products spanning ventilation and cardiorespiratory diagnostics. Its portfolio covers the full spectrum from neonatal to adult care, including invasive and non-invasive ventilation, high-frequency oscillatory ventilation, and airway pressure monitoring devices used by hospitals, ICUs, NICUs, and emergency medical services. Following the October 2024 divestiture of its Ventilator Business Unit to ZOLL Medical, Vyaire retained its Respiratory Diagnostics business unit.

Product overview

Vyaire Medical operated two primary business units: Ventilators and Respiratory Diagnostics. Following the October 2024 acquisition by ZOLL Medical, the Ventilator Business Unit (comprising the bellavista, LTV, 3100 HFOV, and fabian ventilator product lines) transitioned to ZOLL. The Respiratory Diagnostics business unit continues operations independently, serving cardiorespiratory diagnostics customers. The neonatal portfolio was expanded in 2024. Vyaire's ventilator products covered the full spectrum from neonatal to adult care, supporting both invasive and non-invasive ventilation modalities.

Differentiator

Problem solved

Functional benefit

Products and services

• Neonatal Portfolio Expansion
• Respiratory Diagnostics (Retained Business Unit)

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered minor and major.

• MaxtecminorOthers · 3 December 2024Maxtec acquired the Bird MicroBlender product line from Vyaire Medical's ventilator business unit. The acquisition integrates the precision FiO2 delivery device into Maxtec's respiratory care portfolio. Transfer of design and production to Maxtec's U.S. facilities is underway, with planned relaunch and availability of all Bird MicroBlender products and maintenance kits expected by mid-2025 through existing distribution channels.
• ZOLL MedicalmajorOthers · 11 October 2024ZOLL Medical acquired certain assets of Vyaire Medical's Ventilation Business Unit consisting of bellavista, LTV, 3100 HFOV, and fabian ventilator product lines. This included ventilator devices as well as associated consumables, service parts, accessories, and service program offerings. The acquisition was announced in August 2024 and completed on October 11, 2024. Vyaire retained its Respiratory Diagnostics business unit.

Scale indicators3 records

Recent moves8 records

Expansion highlights3 records

Broad incumbents

• ZOLL Medical: Acquired Vyaire's Ventilation Business Unit in October 2024, making ZOLL a direct owner of Vyaire's former bellavista, LTV, 3100 HFOV, and fabian ventilator lines and the closest peer in critical care ventilation.
• GE HealthCare: Major global medical device and diagnostics company with neonatal and ICU ventilation offerings; identified as a competitor in the neonatal ventilators market and a broader hospital equipment incumbent.
• Philips (Philips Respironics): Operates in hospital respiratory care and consumer/sleep ventilation through Philips Respironics; named alongside Vyaire in the neonatal ventilators and breathing trainer markets as a major diversified respiratory competitor.
• Medtronic: Global medical device leader; cited as a key competitor in continuous cuff pressure monitoring devices and in the broader respiratory care and breathing trainer markets alongside Vyaire.

Direct peers

• Drägerwerk AG: Global medical and safety technology company; identified as a direct competitor in continuous cuff pressure monitoring and neonatal ventilation alongside Vyaire, serving the same hospital ICU and NICU customer base.
• Hamilton Medical: Specializes in ICU and neonatal/transport ventilators; named alongside Vyaire as a strategic player in the neonatal ventilators market with overlapping critical care product lines.
• Getinge: Provides ICU ventilators, anesthesia, and critical care equipment; named alongside Vyaire as a strategic player in the neonatal ventilators market with overlapping hospital customer profiles.
• B. Braun: Medical device and infusion technology company with neonatal ventilation products; identified as a competitor in the neonatal ventilators market competing for similar NICU and hospital customers.
• Fisher & Paykel Healthcare: Specializes in respiratory care, humidification, and neonatal products including breathing trainers; listed as a competitor in the detachable breathing trainer market alongside Vyaire.
• ResMed: Global leader in sleep and respiratory care; named as a competitor in the detachable breathing trainer market alongside Vyaire, with overlap in hospital-to-home respiratory product categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/vyaire
• LinkedInlinkedin.com/company/vyaire-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vyaire Medical